UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 111

Sortiert nach

Utility of peak inspiratory flow measurement for dry powder inhaler use in chronic obstructive pulmonary disease

Current opinion in pulmonary medicine, 2024-03, Vol.30 (2), p.174

2024

Link zum Volltext

Verfügbarkeit prüfen

Characteristics and Prevalence of Asthma/Chronic Obstructive Pulmonary Disease Overlap in the United States

Annals of the American Thoracic Society, 2016-06, Vol.13 (6), p.803-810

2016

Link zum Volltext

Verfügbarkeit prüfen

Suboptimal Inspiratory Flow Rates Are Associated with Chronic Obstructive Pulmonary Disease and All-Cause Readmissions

Annals of the American Thoracic Society, 2017-08, Vol.14 (8), p.1305-1311

2017

Link zum Volltext

Verfügbarkeit prüfen

Medicare Bundled Payments for Care Improvement Initiative for Chronic Obstructive Pulmonary Disease Readmissions: A Negative Study That Has Positive Implications

Annals of the American Thoracic Society, 2017-05, Vol.14 (5), p.617-618

Ohar, Jill A

2017

Link zum Volltext

Verfügbarkeit prüfen

Long-Term Noninvasive Ventilation in Chronic Stable Hypercapnic Chronic Obstructive Pulmonary Disease. An Official American Thoracic Society Clinical Practice Guideline

American journal of respiratory and critical care medicine, 2020-08, Vol.202 (4), p.e74-e87

2020

Link zum Volltext

Verfügbarkeit prüfen

Germline BAP1 Mutational Landscape of Asbestos-Exposed Malignant Mesothelioma Patients with Family History of Cancer

Cancer research (Chicago, Ill.), 2016-01, Vol.76 (2), p.206-215

2016

Link zum Volltext

Verfügbarkeit prüfen

Dual therapy strategies for COPD: the scientific rationale for LAMA + LABA

International journal of chronic obstructive pulmonary disease, 2016, Vol.11 (1), p.785-797

2016

Link zum Volltext

Verfügbarkeit prüfen

Novel LRRK2 mutations and other rare, non-BAP1-related candidate tumor predisposition gene variants in high-risk cancer families with mesothelioma and other tumors

Human molecular genetics, 2021-08, Vol.30 (18), p.1750-1761

2021

Link zum Volltext

Verfügbarkeit prüfen

Smoking duration, respiratory symptoms, and COPD in adults aged ≥45 years with a smoking history

International journal of chronic obstructive pulmonary disease, 2015-01, Vol.10 (Issue 1), p.1409-1416

2015

Link zum Volltext

Verfügbarkeit prüfen

Germline BAP1 mutation in a family with high incidence of multiple primary cancers and a potential gene–environment interaction

Cancer letters, 2015-12, Vol.369 (2), p.261-265

2015

Link zum Volltext

Verfügbarkeit prüfen

Risks May Not Be Reasons for COPD Readmissions

Annals of the American Thoracic Society, 2015-09, Vol.12 (9), p.1259-1260

Ohar, Jill A

2015

Link zum Volltext

Verfügbarkeit prüfen

Pharmacotherapy for Chronic Obstructive Pulmonary Disease: Molecules and Delivery Are Equally Important

American journal of respiratory and critical care medicine, 2020-11, Vol.202 (10), p.1482-1482

2020

Link zum Volltext

Verfügbarkeit prüfen

Clinical Burden of Chronic Obstructive Pulmonary Disease in Patients with Suboptimal Peak Inspiratory Flow

Canadian respiratory journal, 2024, Vol.2024, p.8034923-8

2024

Link zum Volltext

Verfügbarkeit prüfen

Peak Inspiratory Flows: Defining Repeatability Limits and a Predictive Equation for Different Inhalers

Chest, 2020-10, Vol.158 (4), p.1413-1419

2020

Link zum Volltext

Verfügbarkeit prüfen

Prevalence and factors associated with suboptimal peak inspiratory flow rates in COPD

International journal of chronic obstructive pulmonary disease, 2019-03, Vol.14, p.585-595

2019

Link zum Volltext

Verfügbarkeit prüfen

Improvements in health status with revefenacin, a once-daily, nebulized, long-acting muscarinic antagonist for chronic obstructive pulmonary disease

Respiratory medicine, 2023-03, Vol.208, p.107123-107123, Article 107123

2023

Link zum Volltext

Verfügbarkeit prüfen

The Role of Guaifenesin in the Management of Chronic Mucus Hypersecretion Associated with Stable Chronic Bronchitis: A Comprehensive Review

Chronic obstructive pulmonary diseases, 2019-10, Vol.6 (4), p.341-349

2019

Link zum Volltext

Verfügbarkeit prüfen

The Role of ICS/LABA Fixed-Dose Combinations in the Treatment of Asthma and COPD: Bioequivalence of a Generic Fluticasone Propionate-Salmeterol Device

Pulmonary medicine, 2021, Vol.2021, p.8881895-7

2021

Link zum Volltext

Verfügbarkeit prüfen

In Vitro Effect of Different Airflow Rates on the Aerosol Properties of Nebulized Glycopyrrolate in the eFlow® Closed System and Tiotropium Delivered in the HandiHaler

Pulmonary therapy, 2020-12, Vol.6 (2), p.289-301

2020

Link zum Volltext

Verfügbarkeit prüfen

Results of a Patient Survey Regarding COPD Knowledge, Treatment Experiences, and Practices With Inhalation Devices

Respiratory care, 2018-07, Vol.63 (7), p.833-839

2018

Link zum Volltext

Verfügbarkeit prüfen

Will Remotely Based Pulmonary Rehabilitation Water Down Its Effectiveness?

Life (Basel, Switzerland), 2021-11, Vol.11 (11), p.1270

2021

Link zum Volltext

Verfügbarkeit prüfen

Chronic Obstructive Pulmonary Disease and Asthma-Patient Characteristics and Health Impairment

Chronic obstructive pulmonary disease, 2014-06, Vol.11 (3), p.256-266

2014

Link zum Volltext

Verfügbarkeit prüfen

Low Peak Inspiratory Flow Rates are Common Among COPD Inpatients and are Associated with Increased Healthcare Resource Utilization: A Retrospective Cohort Study

International journal of chronic obstructive pulmonary disease, 2022-01, Vol.17, p.1483-1494

2022

Link zum Volltext

Verfügbarkeit prüfen

Aerosol Plumes of Inhalers Used in COPD

Pulmonary therapy, 2024-03, Vol.10 (1), p.109-122

2024

Link zum Volltext

Verfügbarkeit prüfen

Changing Pattern in Malignant Mesothelioma Survival

Translational oncology, 2015-02, Vol.8 (1), p.35-39

2015

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 111

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(102)
Mit Volltextzugriff
(99)

Publikationsform

Artikel
(111)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(85)
Science & Technology
(85)
Humans
(65)
Respiratory System
(58)
Female
(40)
Male
(37)
Middle Aged
(34)
Chronic Obstructive Pulmonary Disease
(30)
General & Internal Medicine
(29)
Aged
(28)
Copd
(23)
Adult
(22)
Critical Care Medicine
(22)
Biological And Medical Sciences
(21)
Medical Sciences
(21)
Pulmonary Disease, Chronic Obstructive - Physiopathology
(17)
Original Research
(16)
Pulmonary Disease, Chronic Obstructive - Drug Therapy
(16)
Administration, Inhalation
(14)
Risk Factors
(14)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Utility of peak inspiratory flow measurement for dry powder inhaler use in chronic obstructive pulmonary disease

Characteristics and Prevalence of Asthma/Chronic Obstructive Pulmonary Disease Overlap in the United States

Suboptimal Inspiratory Flow Rates Are Associated with Chronic Obstructive Pulmonary Disease and All-Cause Readmissions

Medicare Bundled Payments for Care Improvement Initiative for Chronic Obstructive Pulmonary Disease Readmissions: A Negative Study That Has Positive Implications

Long-Term Noninvasive Ventilation in Chronic Stable Hypercapnic Chronic Obstructive Pulmonary Disease. An Official American Thoracic Society Clinical Practice Guideline

Germline BAP1 Mutational Landscape of Asbestos-Exposed Malignant Mesothelioma Patients with Family History of Cancer

Dual therapy strategies for COPD: the scientific rationale for LAMA + LABA

Novel LRRK2 mutations and other rare, non-BAP1-related candidate tumor predisposition gene variants in high-risk cancer families with mesothelioma and other tumors

Smoking duration, respiratory symptoms, and COPD in adults aged ≥45 years with a smoking history

Germline BAP1 mutation in a family with high incidence of multiple primary cancers and a potential gene–environment interaction

Risks May Not Be Reasons for COPD Readmissions

Pharmacotherapy for Chronic Obstructive Pulmonary Disease: Molecules and Delivery Are Equally Important

Clinical Burden of Chronic Obstructive Pulmonary Disease in Patients with Suboptimal Peak Inspiratory Flow

Peak Inspiratory Flows: Defining Repeatability Limits and a Predictive Equation for Different Inhalers

Prevalence and factors associated with suboptimal peak inspiratory flow rates in COPD

Improvements in health status with revefenacin, a once-daily, nebulized, long-acting muscarinic antagonist for chronic obstructive pulmonary disease

The Role of Guaifenesin in the Management of Chronic Mucus Hypersecretion Associated with Stable Chronic Bronchitis: A Comprehensive Review

The Role of ICS/LABA Fixed-Dose Combinations in the Treatment of Asthma and COPD: Bioequivalence of a Generic Fluticasone Propionate-Salmeterol Device

In Vitro Effect of Different Airflow Rates on the Aerosol Properties of Nebulized Glycopyrrolate in the eFlow® Closed System and Tiotropium Delivered in the HandiHaler

Results of a Patient Survey Regarding COPD Knowledge, Treatment Experiences, and Practices With Inhalation Devices

Will Remotely Based Pulmonary Rehabilitation Water Down Its Effectiveness?

Chronic Obstructive Pulmonary Disease and Asthma-Patient Characteristics and Health Impairment

Low Peak Inspiratory Flow Rates are Common Among COPD Inpatients and are Associated with Increased Healthcare Resource Utilization: A Retrospective Cohort Study

Aerosol Plumes of Inhalers Used in COPD

Changing Pattern in Malignant Mesothelioma Survival

Suchergebnisse filtern